From FDA approvals to new studies, here are four updates on two-level disc replacement to know, as reported by Becker’s since May 29:
- Centinel Spine received FDA premarket approval Oct. 14 for two-level use of its prodisc C Vivo and prodisc C SK cervical disc replacement devices.
- A 93-year-old woman underwent a successful 2-level lumbar decompression with spinal anesthesia.
- Aclarion enrolled its first patients in a clinical trial designed to reduce back pain at the Texas Back Institute in Plano.
- Hybrid anterior cervical discectomy and fusion and cervical disc replacement is a growing option for multilevel cervical disc degenerative disease, and early fusion rates are stronger, according to a study in the June 2025 issue of The Spine Journal.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
